Jane Street Group, LLC Vaxart, Inc. Put Options Transaction History

Jane Street Group, LLC

7 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 17, 2022	SELL	$4.29 - $6.64 $202,917 - $314,072	-47,300 Reduced 40.29%	70,100 $353,000
Q4 2021 Feb 15, 2022	SELL	$5.77 - $7.96 $857,998 - $1.18 Million	-148,700 Reduced 55.88%	117,400 $736,000
Q3 2021 Nov 16, 2021	SELL	$6.67 - $9.8 $1.2 Million - $1.77 Million	-180,400 Reduced 40.4%	266,100 $2.12 Million
Q2 2021 Aug 16, 2021	BUY	$5.06 - $10.78 $1.2 Million - $2.56 Million	237,300 Added 113.43%	446,500 $3.34 Million
Q1 2021 May 18, 2021	BUY	$5.64 - $23.33 $568,512 - $2.35 Million	100,800 Added 92.99%	209,200 $1.27 Million
Q4 2020 Feb 17, 2021	SELL	$3.5 - $7.98 $326,200 - $743,736	-93,200 Reduced 46.23%	108,400 $619,000
Q3 2020 Nov 17, 2020	BUY	$4.78 - $16.97 $963,648 - $3.42 Million	201,600 New	201,600 $1.34 Million

110

37.6M

188K

180K

Ticker VXRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 126,506,000
Market Cap $79.7M
Description
Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.